Crossmark

COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2022.05.009

Published Print: 2023-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ramos, Laura

Carrillo-Palau, Marta

Alonso-Abreu, Inmaculada

Reygosa, Cristina

Hernández-Alvarez, Noemi

Amaral, Carla

Hernández, Anjara

Benítez-Zafra, Federica

Pérez-González, Fabiola

Quintana-Díaz, Haridian

Hernandez-Guerra, Manuel
Funding

Funding for this research was provided by:

Gilead Sciences

AbbVie
License Information

Text and Data Mining valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01
More Information

This article is maintained by: Elsevier

Article Title: COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2022.05.009

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below